grants

CSL: Announcing Major Expansion of Broadmeadows


Global biopharmaceuticals company, CSL (ASX:CSL) has announced a major expansion of its Broadmeadows facility. Over 8 years, the multi-million dollar expansion will take place, with grant contributions from the Federal and State Governments.

Syndicate content

Recommended Websites